C72.9 - Malignant neoplasm of central nervous system, unspecified
ICD-10: | C72.9 |
Short Description: | Malignant neoplasm of central nervous system, unspecified |
Long Description: | Malignant neoplasm of central nervous system, unspecified |
Status: | Valid for Submission |
Version: | ICD-10-CM 2023 |
Code Classification: |
C72.9 is a billable ICD-10 code used to specify a medical diagnosis of malignant neoplasm of central nervous system, unspecified. The code is valid during the fiscal year 2023 from October 01, 2022 through September 30, 2023 for the submission of HIPAA-covered transactions.
The following anatomical sites found in the Table of Neoplasms reference this diagnosis code given the correct histological behavior: Neoplasm, neoplastic central nervous system ; Neoplasm, neoplastic epidural ; Neoplasm, neoplastic extradural ; Neoplasm, neoplastic motor tract ; Neoplasm, neoplastic nervous system (central) ; Neoplasm, neoplastic parasellar ; etc
Unspecified diagnosis codes like C72.9 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Anaplastic astrocytoma of central nervous system
- Anaplastic ependymoma of central nervous system
- Anaplastic ganglioglioma
- Anaplastic ganglioglioma of central nervous system
- Anaplastic oligoastrocytoma of central nervous system
- Anaplastic oligodendroglioma of central nervous system
- Angiocentric glioma of central nervous system
- Astroblastoma of central nervous system
- Embryonal neuroepithelial neoplasm of central nervous system
- Embryonal neuroepithelial neoplasm of central nervous system
- Embryonal neuroepithelial neoplasm of central nervous system
- Ependymoma of central nervous system
- Fibrillary astrocytoma of central nervous system
- Ganglioneuroblastoma
- Ganglioneuroblastoma of central nervous system
- Gemistocytic astrocytoma of central nervous system
- Germinoma of central nervous system
- Giant cell glioblastoma of central nervous system
- Glioblastoma multiforme of central nervous system
- Glioma
- Glioma of central nervous system
- Gliosarcoma of central nervous system
- Malignant glioma of central nervous system
- Malignant neoplasm of central nervous system
- Malignant neoplasm of nervous system
- Medulloepithelioma
- Medulloepithelioma of central nervous system
- Melanoma and neural system tumor syndrome
- Mixed germ cell neoplasm of central nervous system
- Mixed germ cell tumor
- Mixed glioma
- Neuroblastoma
- Neuroblastoma of central nervous system
- Nongerminomatous germ cell tumor of central nervous system
- Oligodendroglioma
- Overlapping malignant neoplasm of brain and other parts of the central nervous system
- Pilomyxoid astrocytoma
- Primary malignant astrocytoma of central nervous system
- Primary malignant neoplasm of central nervous system
- Primary malignant neoplasm of nervous system
- Primary primitive neuroectodermal neoplasm of central nervous system
- Primitive neuroectodermal tumor
Clinical Information
- Ganglioneuroblastoma-. a moderately malignant neoplasm composed of primitive neuroectodermal cells dispersed in myxomatous or fibrous stroma intermixed with mature ganglion cells. it may undergo transformation into a neuroblastoma. it arises from the sympathetic trunk or less frequently from the adrenal medulla, cerebral cortex, and other locations. cervical ganglioneuroblastomas may be associated with horner syndrome and the tumor may occasionally secrete vasoactive intestinal peptide, resulting in chronic diarrhea.
- Astrocytoma-. neoplasms of the brain and spinal cord derived from glial cells which vary from histologically benign forms to highly anaplastic and malignant tumors. fibrillary astrocytomas are the most common type and may be classified in order of increasing malignancy (grades i through iv). in the first two decades of life, astrocytomas tend to originate in the cerebellar hemispheres; in adults, they most frequently arise in the cerebrum and frequently undergo malignant transformation. (from devita et al., cancer: principles and practice of oncology, 5th ed, pp2013-7; holland et al., cancer medicine, 3d ed, p1082)
- Glioma-. benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). astrocytes may give rise to astrocytomas (astrocytoma) or glioblastoma multiforme (see glioblastoma). oligodendrocytes give rise to oligodendrogliomas (oligodendroglioma) and ependymocytes may undergo transformation to become ependymoma; choroid plexus neoplasms; or colloid cysts of the third ventricle. (from escourolle et al., manual of basic neuropathology, 2nd ed, p21)
- Glioma, Subependymal-. rare, slow-growing, benign intraventricular tumors, often asymptomatic and discovered incidentally. the tumors are classified histologically as ependymomas and demonstrate a proliferation of subependymal fibrillary astrocytes among the ependymal tumor cells. (from clin neurol neurosurg 1997 feb;99(1):17-22)
- Gliosarcoma-. rare mixed tumors of the brain and rarely the spinal cord which contain malignant neuroectodermal (glial) and mesenchymal components, including spindle-shaped fibrosarcoma cells. these tumors are highly aggressive and present primarily in adults as rapidly expanding mass lesions. they may arise in tissue that has been previously irradiated. (from br j neurosurg 1995 apr;9(2):171-8)
- Neoplasms, Neuroepithelial-. neoplasms composed of neuroepithelial cells, which have the capacity to differentiate into neurons, oligodendrocytes, and astrocytes. the majority of craniospinal tumors are of neuroepithelial origin. (from dev biol 1998 aug 1;200(1):1-5)
- Optic Nerve Glioma-. glial cell derived tumors arising from the optic nerve, usually presenting in childhood.
- Retinoblastoma-. a malignant tumor arising from the nuclear layer of the retina that is the most common primary tumor of the eye in children. the tumor tends to occur in early childhood or infancy and may be present at birth. the majority are sporadic, but the condition may be transmitted as an autosomal dominant trait. histologic features include dense cellularity, small round polygonal cells, and areas of calcification and necrosis. an abnormal pupil reflex (leukokoria); nystagmus, pathologic; strabismus; and visual loss represent common clinical characteristics of this condition. (from devita et al., cancer: principles and practice of oncology, 5th ed, p2104)
- Vascular Endothelial Growth Factor A-. the original member of the family of endothelial cell growth factors referred to as vascular endothelial growth factors. vascular endothelial growth factor-a was originally isolated from tumor cells and referred to as "tumor angiogenesis factor" and "vascular permeability factor". although expressed at high levels in certain tumor-derived cells it is produced by a wide variety of cell types. in addition to stimulating vascular growth and vascular permeability it may play a role in stimulating vasodilation via nitric oxide-dependent pathways. alternative splicing of the mrna for vascular endothelial growth factor a results in several isoforms of the protein being produced.
- Zinc Finger Protein GLI1-. a transcriptional activator and oncogene protein that contains two cys2-his2 zinc fingers. two isoforms are expressed; both regulate the expression of specific genes during development of craniofacial features, digits, the central nervous system; and the gastrointestinal tract. they also regulate sonic hedgehog protein signaling and cell proliferation.
- Zinc Finger Protein Gli3-. a zinc finger transcription factor that contains five cys2-his2 zinc fingers and binds to the gli consensus sequence 5'-gggtggtc-3'. the full-length protein functions as a transcriptional activator whereas the truncated c-terminal form functions as a transcriptional repressor of the sonic hedgehog (shh) signaling pathway; a balance between these two forms is critical for limb and digit development. gli3 also plays a critical role in the differentiation and proliferation of chondrocytes.
- Esthesioneuroblastoma, Olfactory-. a malignant olfactory neuroblastoma arising from the olfactory epithelium of the superior nasal cavity and cribriform plate. it is uncommon (3% of nasal tumors) and rarely is associated with the production of excess hormones (e.g., siadh, cushing syndrome). it has a high propensity for multiple local recurrences and bony metastases. (from holland et al., cancer medicine, 3rd ed, p1245; j laryngol otol 1998 jul;112(7):628-33)
- Neuroblastoma-. a common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. this tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (from devita et al., cancer: principles and practice of oncology, 5th ed, pp2099-2101; curr opin oncol 1998 jan;10(1):43-51)
- Oligodendroglioma-. a relatively slow-growing glioma that is derived from oligodendrocytes and tends to occur in the cerebral hemispheres, thalamus, or lateral ventricle. they may present at any age, but are most frequent in the third to fifth decades, with an earlier incidence peak in the first decade. histologically, these tumors are encapsulated, relatively avascular, and tend to form cysts and microcalcifications. neoplastic cells tend to have small round nuclei surrounded by unstained nuclei. the tumors may vary from well-differentiated to highly anaplastic forms. (from devita et al., cancer: principles and practice of oncology, 5th ed, p2052; adams et al., principles of neurology, 6th ed, p655)
- Horner Syndrome-. a syndrome associated with defective sympathetic innervation to one side of the face, including the eye. clinical features include miosis; mild blepharoptosis; and hemifacial anhidrosis (decreased sweating)(see hypohidrosis). lesions of the brain stem; cervical spinal cord; first thoracic nerve root; apex of the lung; carotid artery; cavernous sinus; and apex of the orbit may cause this condition. (from miller et al., clinical neuro-ophthalmology, 4th ed, pp500-11)
Tabular List of Diseases and Injuries
The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to this diagnosis code:
Inclusion Terms
Inclusion TermsThese terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
- Malignant neoplasm of unspecified site of central nervous system
- Malignant neoplasm of nervous system NOS
Convert to ICD-9 Code
Source ICD-10 Code | Target ICD-9 Code | |
---|---|---|
C72.9 | 192.8 - Mal neo nervous syst NEC | |
Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code. | ||
C72.9 | 192.9 - Mal neo nervous syst NOS | |
Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code. |
Table of Neoplasms
This code is referenced in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.
Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.
Neoplasm, neoplastic | Malignant Primary |
Malignant Secondary |
CaInSitu | Benign | Uncertain Behavior |
Unspecified Behavior |
---|---|---|---|---|---|---|
»Neoplasm, neoplastic »central nervous system | C72.9 | C79.40 | ||||
»Neoplasm, neoplastic »epidural | C72.9 | C79.49 | D33.9 | D43.9 | D49.7 | |
»Neoplasm, neoplastic »extradural | C72.9 | C79.49 | D33.9 | D43.9 | D49.7 | |
»Neoplasm, neoplastic »motor tract | C72.9 | C79.49 | D33.9 | D43.9 | D49.7 | |
»Neoplasm, neoplastic »nervous system (central) | C72.9 | C79.40 | D33.9 | D43.9 | D49.7 | |
»Neoplasm, neoplastic »parasellar | C72.9 | C79.49 | D33.9 | D43.8 | D49.7 |
Patient Education
Cancer
Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for where they start. For example, lung cancer starts in the lung, and breast cancer starts in the breast. The spread of cancer from one part of the body to another is called metastasis. Symptoms and treatment depend on the cancer type and how advanced it is. Most treatment plans may include surgery, radiation and/or chemotherapy. Some may involve hormone therapy, immunotherapy or other types of biologic therapy, or stem cell transplantation.
NIH: National Cancer Institute
[Learn More in MedlinePlus]
Brain Tumors-Patient Version
Learn about brain and spinal cord tumor risk factors, symptoms, tests to diagnose, factors affecting prognosis, and treatment.[Learn More in MedlinePlus]
Code History
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)